Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study.

Rheumatology (Oxford, England)

Volumn 50, Issue 11, 2011, Pages 2061-2070

  Visvanathan, Sudha ^a   Rahman, Mahboob U ^b   Hoffman, Gary S ^b   Xu, Stephen ^b   García Martínez, Ana ^b   Segarra, Marta ^b   Lozano, Ester ^b   Espígol Frigolé, Georgina ^b   Hernández Rodríguez, José ^b   Cid, Maria C ^b  

^a CENTOCOR INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; GLUCOCORTICOID; INFLIXIMAB; INTERLEUKIN 12P40; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; GENE EXPRESSION; GENETICS; GIANT CELL ARTERITIS; HUMAN; METABOLISM; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REMISSION;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; GENE EXPRESSION; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; RNA, MESSENGER;

EID: 84855161422     PISSN: None     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ker163     Document Type: Article

References (0)